The growing field of immunotherapy relies heavily on recombinant mediator technology, and a thorough understanding of individual profiles is paramount for optimizing experimental design and therapeutic efficacy. https://altbookmark.com/story22829088/analyzing-recombinant-growth-factor-profiles-il-1a-il-1b-il-2-and-il-3